MI:RNA Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.6M

  • Investors
  • 16

MI:RNA General Information

Description

Operator of a veterinary diagnostics company intended to develop and market testing technology for early-stage heart disease in companion animals. The company specializes in the development of testing technology for veterinary diseases and offers companion animal tests using serum biomarkers and AI modeling, enabling pets to improve treatment outcomes and quality of life for pets.

Contact Information

Website
mirna.tech
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scotland's Rural College, Room 16
  • Peter Wilson Building Basement, West Mains Road
  • Edinburgh EH9 3JG
  • Scotland, United Kingdom
+44 0131
Primary Industry
Diagnostic Equipment
Other Industries
Other Services (B2C Non-Financial)
Vertical(s)
Corporate Office
  • Scotland's Rural College, Room 16
  • Peter Wilson Building Basement, West Mains Road
  • Edinburgh EH9 3JG
  • Scotland, United Kingdom
+44 0131

MI:RNA Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MI:RNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 10-Dec-2025 $3.6M Completed Generating Revenue
5. Later Stage VC (Series A) 03-Jul-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jul-2024 Completed Generating Revenue
3. Seed Round 01-Aug-2023 Completed Generating Revenue
2. Accelerator/Incubator 04-Mar-2023 $200K $200K Completed Generating Revenue
1. University Spin-Out 01-Jan-2019 Completed Generating Revenue
To view MI:RNA’s complete valuation and funding history, request access »

MI:RNA Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Ordinary 26,267 $0.001270 $26.58 $26.58 1x $26.58 10.38%
Ordinary 7,421 $0.001270 $18.48 $18.48 1x $18.48 2.93%
To view MI:RNA’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MI:RNA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MI:RNA Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ani.VC Venture Capital Minority
Holstein UK VC-Backed Company Minority
Animal Health Angels Angel Group Minority
Gabriel Investment Syndicate Angel Group Minority
Kyoritsu Holdings Corporation Minority
You’re viewing 5 of 16 investors. Get the full list »

MI:RNA FAQs

  • When was MI:RNA founded?

    MI:RNA was founded in 2019.

  • Where is MI:RNA headquartered?

    MI:RNA is headquartered in Edinburgh, United Kingdom.

  • What is the size of MI:RNA?

    MI:RNA has 36 total employees.

  • What industry is MI:RNA in?

    MI:RNA’s primary industry is Diagnostic Equipment.

  • Is MI:RNA a private or public company?

    MI:RNA is a Private company.

  • What is MI:RNA’s current revenue?

    The current revenue for MI:RNA is .

  • How much funding has MI:RNA raised over time?

    MI:RNA has raised $9.2M.

  • Who are MI:RNA’s investors?

    Ani.VC, Holstein UK, Animal Health Angels, Gabriel Investment Syndicate, and Kyoritsu Holdings are 5 of 16 investors who have invested in MI:RNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process